vs
Side-by-side financial comparison of AVALON HOLDINGS CORP (AWX) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
AVALON HOLDINGS CORP is the larger business by last-quarter revenue ($21.5M vs $18.3M, roughly 1.2× ROCKWELL MEDICAL, INC.). AVALON HOLDINGS CORP runs the higher net margin — -1.7% vs -3.0%, a 1.4% gap on every dollar of revenue. On growth, AVALON HOLDINGS CORP posted the faster year-over-year revenue change (21.7% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-166.0K). Over the past eight quarters, AVALON HOLDINGS CORP's revenue compounded faster (6.7% CAGR vs -10.1%).
Avalon Hill Games Inc. is a game company that publishes wargames and strategic board games. It has also published miniature wargaming rules, role-playing games and sports simulations. It is a subsidiary of Hasbro, and operates under the company's "Hasbro Gaming" division.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
AWX vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.5M | $18.3M |
| Net Profit | $-356.0K | $-554.0K |
| Gross Margin | 17.1% | 21.1% |
| Operating Margin | 0.4% | -2.2% |
| Net Margin | -1.7% | -3.0% |
| Revenue YoY | 21.7% | -25.6% |
| Net Profit YoY | 28.4% | 26.7% |
| EPS (diluted) | — | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.5M | $18.3M | ||
| Q3 25 | $25.7M | $15.9M | ||
| Q2 25 | $20.3M | $16.1M | ||
| Q1 25 | $16.1M | $18.9M | ||
| Q4 24 | $17.6M | $24.7M | ||
| Q3 24 | $24.2M | $28.3M | ||
| Q2 24 | $23.1M | $25.8M | ||
| Q1 24 | $18.9M | $22.7M |
| Q4 25 | $-356.0K | $-554.0K | ||
| Q3 25 | $1.9M | $-1.8M | ||
| Q2 25 | $274.0K | $-1.5M | ||
| Q1 25 | $-1.5M | $-1.5M | ||
| Q4 24 | $-497.0K | $-756.0K | ||
| Q3 24 | $1.8M | $1.7M | ||
| Q2 24 | $954.0K | $343.0K | ||
| Q1 24 | $-979.0K | $-1.7M |
| Q4 25 | 17.1% | 21.1% | ||
| Q3 25 | 23.7% | 14.3% | ||
| Q2 25 | 20.6% | 15.6% | ||
| Q1 25 | 14.8% | 16.1% | ||
| Q4 24 | 17.5% | 14.7% | ||
| Q3 24 | 24.6% | 22.0% | ||
| Q2 24 | 22.1% | 17.6% | ||
| Q1 24 | 16.2% | 13.5% |
| Q4 25 | 0.4% | -2.2% | ||
| Q3 25 | 9.1% | -9.9% | ||
| Q2 25 | 3.7% | -8.4% | ||
| Q1 25 | -7.2% | -7.2% | ||
| Q4 24 | -0.8% | -2.1% | ||
| Q3 24 | 9.4% | 6.8% | ||
| Q2 24 | 6.3% | 2.0% | ||
| Q1 24 | -2.7% | -5.8% |
| Q4 25 | -1.7% | -3.0% | ||
| Q3 25 | 7.4% | -11.0% | ||
| Q2 25 | 1.4% | -9.3% | ||
| Q1 25 | -9.3% | -8.0% | ||
| Q4 24 | -2.8% | -3.1% | ||
| Q3 24 | 7.6% | 5.9% | ||
| Q2 24 | 4.1% | 1.3% | ||
| Q1 24 | -5.2% | -7.6% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $38.4M | $37.0M |
| Total Assets | $87.4M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $10.7M | ||
| Q3 25 | $4.6M | $13.6M | ||
| Q2 25 | $3.7M | $12.5M | ||
| Q1 25 | $1.3M | $11.4M | ||
| Q4 24 | $2.8M | $15.7M | ||
| Q3 24 | $3.9M | $12.3M | ||
| Q2 24 | $3.8M | $11.9M | ||
| Q1 24 | $1.2M | $6.6M |
| Q4 25 | $38.4M | $37.0M | ||
| Q3 25 | $38.7M | $37.0M | ||
| Q2 25 | $36.8M | $30.4M | ||
| Q1 25 | $36.5M | $31.5M | ||
| Q4 24 | $38.0M | $32.6M | ||
| Q3 24 | $38.5M | $29.1M | ||
| Q2 24 | $36.7M | $23.5M | ||
| Q1 24 | $35.7M | $20.6M |
| Q4 25 | $87.4M | $57.1M | ||
| Q3 25 | $90.7M | $57.5M | ||
| Q2 25 | $88.1M | $52.6M | ||
| Q1 25 | $87.6M | $54.0M | ||
| Q4 24 | $86.2M | $59.2M | ||
| Q3 24 | $89.1M | $57.1M | ||
| Q2 24 | $91.7M | $53.0M | ||
| Q1 24 | $90.6M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.0K | $2.3M |
| Free Cash FlowOCF − Capex | $-166.0K | $2.2M |
| FCF MarginFCF / Revenue | -0.8% | 12.0% |
| Capex IntensityCapex / Revenue | 2.1% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.0K | $2.3M | ||
| Q3 25 | $1.5M | $-1.3M | ||
| Q2 25 | $3.0M | $1.8M | ||
| Q1 25 | $-982.0K | $-3.5M | ||
| Q4 24 | $-579.0K | $865.0K | ||
| Q3 24 | $342.0K | $4.3M | ||
| Q2 24 | $3.2M | $1.4M | ||
| Q1 24 | $411.0K | $-2.4M |
| Q4 25 | $-166.0K | $2.2M | ||
| Q3 25 | $852.0K | $-1.5M | ||
| Q2 25 | $2.7M | $1.7M | ||
| Q1 25 | $-1.4M | $-3.5M | ||
| Q4 24 | $-1.1M | $470.0K | ||
| Q3 24 | $-660.0K | $4.1M | ||
| Q2 24 | $2.9M | $1.2M | ||
| Q1 24 | $56.0K | $-2.5M |
| Q4 25 | -0.8% | 12.0% | ||
| Q3 25 | 3.3% | -9.6% | ||
| Q2 25 | 13.5% | 10.5% | ||
| Q1 25 | -8.5% | -18.8% | ||
| Q4 24 | -6.4% | 1.9% | ||
| Q3 24 | -2.7% | 14.4% | ||
| Q2 24 | 12.4% | 4.5% | ||
| Q1 24 | 0.3% | -11.1% |
| Q4 25 | 2.1% | 0.5% | ||
| Q3 25 | 2.3% | 1.4% | ||
| Q2 25 | 1.4% | 1.0% | ||
| Q1 25 | 2.4% | 0.3% | ||
| Q4 24 | 3.1% | 1.6% | ||
| Q3 24 | 4.1% | 0.7% | ||
| Q2 24 | 1.5% | 1.1% | ||
| Q1 24 | 1.9% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 11.07× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.19× | 2.57× | ||
| Q2 24 | 3.35× | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AWX
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
